MedTrace Logo

Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer

NCT02609321 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-12-26

No results posted yet for this study

Summary

Surgical treatment of breast cancer is frequently associated with postoperative pain in the surgical area. Persistent pain after breast cancer management has considerable negative effects on the quality of life of survivors. The aim of this trials is to evaluate the efficacy of thoracic paravertebral block with bupivacine 0.5% in reducing the acute pain postmastectomy compare with surgical wound infiltration with bupivacaine 0.5%.

Conditions

Interventions

PROCEDURE

Thoracic Paravertebral Block

Thoracic paravertebral block at T3 level with bupivacaine 0.5%, dosis 1.5mg/Kg

PROCEDURE

Surgical Wound Infiltration

Surgical wound infiltration on the skin and subcutaneous tissue in surgical area with bipivacaine 0.5%, dosis 1.5mg/kg

Sponsors & Collaborators

  • Instituto de Cancerología S.A.

    lead OTHER

Principal Investigators

  • Fernando Herazo, MD, MSc · Instituto de Cancerología IDC Las Américas

  • Hector I García, MD, MPH, MSc · Instituto de Cancerología IDC Las Américas

  • Jorge A Egurrola, MD · Instituto de Cancerología IDC Las Américas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-08-31
Completion
2016-12-31

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02609321 on ClinicalTrials.gov